BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31711348)

  • 1. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.
    Ferrero S; Scala C; Ciccarelli S; Vellone VG; Barra F
    Gynecol Endocrinol; 2020 Jun; 36(6):540-544. PubMed ID: 31711348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis.
    Fedele L; Bianchi S; Zanconato G; Portuese A; Raffaelli R
    Fertil Steril; 2001 Mar; 75(3):485-8. PubMed ID: 11239528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
    Margatho D; Carvalho NM; Bahamondes L
    Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):133-140. PubMed ID: 32069126
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis.
    Morotti M; Venturini PL; Biscaldi E; Racca A; Calanni L; Vellone VG; Stabilini C; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():4-10. PubMed ID: 28384540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study.
    Sansone A; De Rosa N; Giampaolino P; Guida M; Laganà AS; Di Carlo C
    Arch Gynecol Obstet; 2018 Oct; 298(4):731-736. PubMed ID: 30074068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.
    Niu X; Luo Q; Wang C; Zhu L; Huang L
    Medicine (Baltimore); 2021 Feb; 100(6):e24597. PubMed ID: 33578561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
    Morotti M; Sozzi F; Remorgida V; Venturini PL; Ferrero S
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():188-92. PubMed ID: 25461377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.
    Margatho D; Mota Carvalho N; Eloy L; Bahamondes L
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):344-350. PubMed ID: 30372645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device.
    Ferrero S; Tramalloni D; Venturini PL; Remorgida V
    Int J Gynaecol Obstet; 2011 May; 113(2):116-9. PubMed ID: 21333989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study.
    Leone Roberti Maggiore U; Remorgida V; Scala C; Tafi E; Venturini PL; Ferrero S
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):239-47. PubMed ID: 24372517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis.
    Yucel N; Baskent E; Karamustafaoglu Balci B; Goynumer G
    Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):560-563. PubMed ID: 29359457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome.
    Buyers E; Sass AE; Severn CD; Pyle L; Cree-Green M
    J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):33-39. PubMed ID: 32919086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone treatment as first line therapy is safe and relieves pelvic pain in women with bowel endometriosis.
    Andres MP; Mendes RFP; Hernandes C; Araújo SEA; Podgaec S
    Einstein (Sao Paulo); 2019 May; 17(2):eAO4583. PubMed ID: 31066795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study about diagnosis and management on 10 women with rectovaginal endometriosis].
    Wang HB; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):277-9. PubMed ID: 12895310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate.
    Vercellini P; Pietropaolo G; De Giorgi O; Pasin R; Chiodini A; Crosignani PG
    Fertil Steril; 2005 Nov; 84(5):1375-87. PubMed ID: 16275232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum.
    Fedele L; Bianchi S; Zanconato G; Tozzi L; Raffaelli R
    Am J Obstet Gynecol; 2000 Dec; 183(6):1462-7. PubMed ID: 11120511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
    Tanmahasamut P; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Indhavivadhana S; Leerasiri P
    Obstet Gynecol; 2012 Mar; 119(3):519-26. PubMed ID: 22314873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.